FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with biochemical trials: before the onset of therapy in men one should detect blood content of thyroid hormone - free thyroxine - and at its level being 10.3-12.9 pmol/l one should diagnose mammary cancer, at the level of free throxine being 18.7-31.0 pmol/l - one should predict gynecomastia. The method enables to detect the direction of pathological process and carry out due correction of therapy tactics in men with either gynecomastia or mammary cancer.
EFFECT: higher accuracy of diagnostics.
4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING EFFICIENCY OF AUTOHEMOCHEMOTHERAPY IN PATIENTS WITH CANCER OF MOUTH CAVITARY AND PHARYNGEAL ORGANS | 2003 |
|
RU2253354C2 |
| METHOD FOR PREDICTING CEREBRAL METASTASIS LESION FOCI IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300109C2 |
| METHOD OF PROGNOSING GENERALIZATION OF PROCESS IN CHILDREN AND ADOLESCENTS WITH OSTEAL SARCOMA | 2004 |
|
RU2282195C2 |
| METHOD FOR CORRECTING FUNCTIONAL MELATONIN PRODUCTION ACTIVITY OF EPIPHYSIS IN TREATING THE CASES OF LUNG CANCER | 2002 |
|
RU2241221C2 |
| METHOD FOR DETECTING EXTRACRANIAL METASTASES IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300110C2 |
| METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER | 2007 |
|
RU2328747C1 |
| METHOD FOR PRE-OPERATIONAL TREATMENT OF MAMMARY CANCER | 2004 |
|
RU2265440C2 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
| METHOD FOR PREDICTING METASTASIS AND FLOW OF TUMOR PROCESS IN PATIENTS WITH PULMONARY CANCER | 2002 |
|
RU2214605C1 |
